Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Godfried

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
AIDS (London, England)|January 1, 1993
Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infectionM H Godfried, T van der Poll, J Jansen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 20, 2007
The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal deliveryK Boer, J F Nellen, D Patel, et al.
Metabolism: Clinical and Experimental|December 1, 1995
Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infectionM H Godfried, J A Romijn, T van der Poll, et al.
Journal of Neuroimmunology|November 1, 1993
Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complexP Portegies, M H Godfried, R Q Hintzen, et al.
HIV Medicine|March 28, 2008
Steady-state nevirapine plasma concentrations are influenced by pregnancyJ F J B Nellen, M Damming, M H Godfried, et al.
AIDS (London, England)|January 25, 2017
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's replyL Denneman, S Cohen, M H Godfried, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
AIDS (London, England)|January 1, 1993
Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infectionM H Godfried, T van der Poll, J Jansen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 20, 2007
The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal deliveryK Boer, J F Nellen, D Patel, et al.
Metabolism: Clinical and Experimental|December 1, 1995
Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infectionM H Godfried, J A Romijn, T van der Poll, et al.
Journal of Neuroimmunology|November 1, 1993
Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complexP Portegies, M H Godfried, R Q Hintzen, et al.
HIV Medicine|March 28, 2008
Steady-state nevirapine plasma concentrations are influenced by pregnancyJ F J B Nellen, M Damming, M H Godfried, et al.
AIDS (London, England)|January 25, 2017
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's replyL Denneman, S Cohen, M H Godfried, et al.
Pageof 3